How Long After STI Treatment Should I Retest? A Clear Timeline

After completing STI treatment, you should wait 3–4 weeks before retesting for bacterial infections like chlamydia, gonorrhea, and syphilis. Testing too soon produces false negatives because dead bacterial DNA can still be detected by PCR tests. For HIV and hepatitis, the window periods are different and longer. The exact timing depends on the specific infection and the type of test used.

• Chlamydia and gonorrhea: retest 3–4 weeks after finishing antibiotics

• Syphilis: retest at 3, 6, and 12 months after treatment to confirm the RPR titre has fallen

• HIV: retest timing depends on the reason for retesting — post-treatment monitoring differs from post-exposure testing

• Trichomoniasis: retest at 3 months, particularly in women, as reinfection rates are high

• Testing too early after antibiotic treatment gives false negatives — dead bacterial DNA still triggers a positive PCR result

Why Retesting Matters

Retesting after STI treatment serves two distinct purposes that are worth separating clearly. The first is a test of cure — confirming that the treatment actually eliminated the infection. The second is surveillance for reinfection — checking whether you have been re-exposed after a successful treatment. The timing and approach differ for each purpose, and the right strategy depends on which question you are trying to answer.

For bacterial STIs especially, retesting is not optional. Antibiotic resistance is an increasing problem in gonorrhea in particular, and a treatment that should work may occasionally fail. Without a test of cure, a treatment failure goes undetected while the infection continues to cause damage and transmission. For chlamydia and gonorrhea, the CDC recommends a test of cure in specific situations, and routine retesting at 3 months for all patients given the high rates of reinfection.

Retesting Timeline by Infection

Chlamydia

The standard recommendation is to wait 3–4 weeks after completing antibiotic treatment before retesting. The reason for waiting is specific to how PCR tests work: they detect bacterial DNA, and DNA from bacteria killed by antibiotics can persist in the sample for up to 3 weeks after the infection has been cleared. Testing at day 7 or day 14 will frequently return a positive result even when treatment was fully successful, leading to unnecessary retreatment and confusion.

After the 3–4 week test of cure, the CDC recommends retesting for chlamydia at 3 months after the initial diagnosis regardless of whether you believe you have been re-exposed. This is because reinfection rates are high — studies consistently show that a significant proportion of people treated for chlamydia test positive again within 3–6 months, most often because a partner was not simultaneously treated.

Gonorrhea

Gonorrhea retesting is particularly important given the rising prevalence of antibiotic-resistant strains. The current standard treatment is a single intramuscular injection of ceftriaxone, but treatment failures — while still uncommon — do occur and need to be detected. The CDC recommends a test of cure 1–2 weeks after treatment for gonorrhea in specific circumstances, including pharyngeal (throat) gonorrhea, which is harder to treat than genital gonorrhea and more likely to fail standard treatment. For genital gonorrhea treated with the current recommended regimen, a test of cure is not routinely required if symptoms resolve — but retesting at 3 months for reinfection is recommended. If symptoms persist or return after treatment, a test of cure should be performed promptly.

Syphilis

Syphilis monitoring after treatment is more complex than for chlamydia or gonorrhea because the test used — the RPR (Rapid Plasma Reagin) — measures antibody levels rather than detecting the bacteria directly. After successful treatment, RPR titres should decline over time. The expected pattern is a fourfold decrease in titre within 6–12 months for primary and secondary syphilis, and within 12–24 months for latent syphilis. Retesting is recommended at 3, 6, and 12 months after treatment. A titre that fails to decline as expected suggests treatment failure or reinfection, both of which require further evaluation and retreatment. RPR titres in some people never return to zero even after successful treatment — a phenomenon called serofast reaction — which is clinically significant and needs to be distinguished from active ongoing infection.

Trichomoniasis

Trichomoniasis is curable with a single dose of metronidazole or tinidazole, and cure rates are high. However, reinfection rates are also high — studies suggest that up to 17% of women retest positive within 3 months. This is almost always due to reinfection from an untreated partner rather than treatment failure. The CDC recommends retesting for trichomoniasis at 3 months after treatment, particularly for women. Partners should be treated simultaneously to prevent the common ping-pong reinfection pattern.

HIV

HIV retesting after treatment has a different meaning depending on context. For people newly diagnosed with HIV who have started antiretroviral therapy, viral load monitoring — rather than an HIV test — is the appropriate measure of treatment response. Viral load should be checked 2–4 weeks after starting treatment, then at 4–8 weeks, and then every 3–6 months once stable. The goal is an undetectable viral load, typically defined as below 200 copies/mL. For people who have had a potential HIV exposure and are considering whether they need to retest, the window period for a 4th generation combination antigen/antibody test is 18–45 days. A negative result at 45 days is highly reliable; a confirmatory test at 90 days provides maximum certainty.

Hepatitis B

For hepatitis B, the natural history of the infection determines monitoring rather than a simple test of cure. Most adult infections resolve spontaneously within 6 months. Chronic hepatitis B — defined as infection persisting beyond 6 months — is managed with antivirals and requires ongoing liver function monitoring rather than a retest for the infection itself. Sexual partners of people with hepatitis B should be tested and vaccinated if not already immune.

The Reinfection Problem

The most common reason people test positive after completing STI treatment is not treatment failure — it is reinfection. This happens overwhelmingly because the partner was not tested and treated at the same time. If you complete a chlamydia treatment course but your partner does not, and you resume sexual activity, reinfection within days to weeks is almost certain. This is why partner treatment is not optional — it is the most important factor in preventing the positive retest that brings people back to the clinic 3–6 weeks after treatment.

The practical implications are straightforward: both you and your partner should be tested, both should be treated if indicated, and sexual activity should be avoided until both have completed treatment. For chlamydia and gonorrhea, this means abstaining for 7 days after completing a single-dose treatment or for the duration of a 7-day antibiotic course.

When to Test Earlier Than Recommended

The 3–4 week window for retesting after bacterial STI treatment applies to asymptomatic people who completed treatment and have no reason to suspect failure. Test sooner if symptoms have not resolved or have worsened after completing treatment — this could indicate treatment failure, a co-infection with a different organism, or antibiotic resistance. Test sooner if you have had unprotected sex with a new or untested partner after treatment, as reinfection can occur quickly. Test sooner if you develop new symptoms consistent with an STI, even if these differ from your original presentation.

Tips for Managing Retesting

• Set a calendar reminder at the time of your treatment — 3–4 weeks for chlamydia/gonorrhea test of cure, 3 months for reinfection surveillance.

• Treat your partner simultaneously — the single most effective thing you can do to avoid a positive retest is ensuring your partner is treated at the same time as you, not sequentially.

• Abstain during treatment — for chlamydia and gonorrhea, avoid sexual contact for 7 days after single-dose treatment or for the entire duration of a 7-day course.

• Request a test of cure specifically when booking — some clinics do not automatically schedule follow-up. Ask explicitly for a retest at the appropriate interval.

• Do not retest within the first 2 weeks after finishing antibiotics for chlamydia or gonorrhea — dead bacterial DNA will produce a false positive and you will be treated unnecessarily.

Frequently Asked Questions

How long after chlamydia treatment should I retest?

Wait 3–4 weeks after completing antibiotic treatment before retesting. Testing earlier risks a false positive because PCR tests detect bacterial DNA which can persist for up to 3 weeks after the bacteria have been killed by antibiotics. After confirming cure, retest again at 3 months to check for reinfection.

Can I test positive for chlamydia right after treatment even if the treatment worked?

Yes. This is one of the most common sources of confusion after STI treatment. PCR tests detect DNA from dead bacteria for up to 3 weeks after successful antibiotic treatment. A positive result in the first 2–3 weeks after treatment does not mean treatment failed — it means you tested too soon. Wait 3–4 weeks before retesting to get a meaningful result.

What does it mean if I test positive again 4 weeks after treatment?

A positive result at 4 weeks or later after completing treatment either means treatment failed — less common but possible, particularly with gonorrhea — or that you were reinfected, typically from a partner who was not treated. Both require retreatment. If this happens, inform your sexual health provider so they can advise on the appropriate next steps and partner notification.

How long should I wait to have sex after STI treatment?

For chlamydia and gonorrhea: 7 days after completing a single-dose treatment, or until you have finished a 7-day antibiotic course. For syphilis: until your provider confirms the treatment is working based on follow-up blood tests. For trichomoniasis: 7 days after a single-dose treatment. Both you and any partners you have treated need to have completed treatment before resuming sexual activity.

Is a test of cure required after all STI treatments?

Not universally, but it is recommended in specific situations. A test of cure is particularly important for gonorrhea (due to resistance concerns), pharyngeal gonorrhea, syphilis (monitoring RPR titre decline), and any STI where symptoms do not resolve after treatment. For uncomplicated genital chlamydia treated with doxycycline, a test of cure is not always mandated if symptoms resolved — but retesting at 3 months for reinfection is always advisable.

Get Retested at the Right Time

Completing treatment is not the end of the process — retesting at the right interval confirms it worked and catches reinfection early. Fast, confidential retesting is available at sexual health clinics and through online home testing services.

Related reading: How Often Should You Get Tested? · What to Do If You Test Positive · The Rise of Antibiotic-Resistant STDs · Chlamydia: Why Regular Testing Is Essential